All Stories

  1. GLAGOV-PASTERKAMP ARTERIAL REMODELING WITH ATHEROPROTECTIVE PHENOMENON AFTER TRANSIENT SCAFFOLDING WITH FIRST-GENERATION POLYMERIC BIORESORBABLE SCAFFOLD
  2. Nanoparticles for treatment of atherosclerosis: challenges of plasmonic photothermal therapy in translational studies
  3. Translational Exploration and Clinical Testing of Silica–Gold Nanoparticles in Development of Multifunctional Nanoplatform for Theranostics of Atherosclerosis
  4. Plasmonic photothermal therapy of atherosclerosis with nanoparticles: long-term outcomes and safety in NANOM-FIM trial
  5. WITHDRAWN: What exactly, regression of atherosclerosis or foreign body reaction with hyaline arteriosclerosis, drives transient scaffolding of coronary arteries? A pooled analysis of observational ABSORB studies with a serial multimodality imaging subs...
  6. Cardiovascular burden and percutaneous interventions in Russian Federation: systematic epidemiological update
  7. Glimpse into the Future of Nanotheranostic Strategies for Regression of Atherosclerosis through the Prism of Systems Biomedicine: Systematic Review of Innovations from Multifunctional Nanoformulations to Devices on Chip
  8. TCT-854 Cardiovascular Burden and Percutaneous Interventions in Russia: Epidemiological Update and Results of National Screening
  9. Scaffold thrombosis: Exaggerated illusion, or when statistics rules
  10. CRT-800.01 Glagovian Window of External Elastic Membrane Enlargement As Cornerstone Phenomenon of Artery Remodeling in Natural History of Atherosclerosis: Subanalysis of NANOM-FIM Trial
  11. CRT-600.03 Optical Coherence Tomography-adapted Score as Tool for In-vivo Coronary Artery Injury Evaluation: Subanalysis of NANO ACTIVE FIM-IN Study
  12. CRT-500.00 Phenomenon of Elongated Struts and Accuracy of Optical Coherence Tomography to Calculate Scaffold Area: Subanalysis of ABSORB Cohort B Trial
  13. CRT-200.09 Grain Domains on Surface of Red Blood Cells as Mirror of Nanotoxicity in Patients Underwent Plasmonic Photothermal Therapy of Atherosclerosis With Silica-Gold Nanoparticles: Subanalysis of NANOM-FIM Trial
  14. Bioresorbable Scaffolds for Atheroregression: Understanding of Transient Scaffolding
  15. Why do we fail to achieve Glagovian atheroregression in lipid-lowering trials?
  16. Silica–gold nanoparticles for atheroprotective management of plaques: results of the NANOM-FIM trial
  17. Responses to: The codex of science: honesty, precision, and truth—and its violations
  18. Can we adapt histological injury score for optical coherence tomography of coronaries?
  19. Phenomenon of elongated struts: Is optical coherence tomography accurate enough to analyze scaffold area?
  20. TCT-304 Retrospective analysis of long-term outcomes in NANOM-FIM trial: safety of plasmonicphotothermal therapy of atherosclerosis
  21. TCT-303 Optimal interventional strategy in patients underwent plasmonicphotothermal therapy of atherosclerosis: subanalysis of NANOM-FIM trial
  22. Progress in Treatment by Percutaneous Coronary Intervention: The Stent of the Future
  23. Avances en el tratamiento mediante intervención coronaria percutánea: el stent del futuro
  24. Emerging technologies: polymer-free phospholipid encapsulated sirolimus nanocarriers for the controlled release of drug from a stent-plus-balloon or a stand-alone balloon catheter
  25. Plasmonic photothermal therapy for atheroregression below Glagov threshold
  26. Do we have a future with transcatheter adventitial delivery of stem cells?
  27. New Revolution in Vascular Interventional Medicine: Bioresorbable Scaffolds for Atheroregression
  28. Glagov Atheroregression below Threshold of 40% Plaque Burden:Achievements and New Horizons
  29. Freeing the vessel from metallic cage: what can we achieve with bioresorbable vascular scaffolds?
  30. Plasmonic Photothermic and Stem Cell Therapy of Atherosclerotic Plaque As a Novel Nanotool for Angioplasty and Artery Remodeling
  31. Plasmonics for Treatment of Atherosclerosis: Results of NANOM-FIM Trial